-
Sector Analysis
Dyslipidemia in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Dyslipidemia Market Report Overview The dyslipidemia market size across the 7MM was valued at $5.56 billion in 2022 and the market will achieve a CAGR of more than 10% during 2022-2032. The growth is attributed to the improved awareness about the health risks associated with dyslipidemia and growing efforts in screening and diagnosis are expected to lead to timely diagnosis of patients with this condition. Dyslipidemia Market Outlook, 2022-2032 ($ Billion) Buy Full Report to Know More About the Dyslipidemia...
-
Sector Analysis
Dyslipidemia Epidemiology Analysis and Forecast to 2032
Dyslipidemia Epidemiology Analysis Report Overview In the 7MM, there were 287,608,383 diagnosed prevalent cases of Dyslipidemia in 2022. The cases are expected to achieve an AGR of less than 1% during the period 2022-2032. The following are some of the key highlights of the Dyslipidemia epidemiology analysis report: Of the 7MM, the US is expected to have the highest number of total prevalent cases, and Italy will have the lowest number of total prevalent cases of dyslipidemia in 2032. In...
-
Sector Analysis
Painful Diabetic Neuropathy Epidemiology Analysis and Forecast to 2031
Painful Diabetic Neuropathy Market Report Overview The total prevalent cases of Painful Diabetic Neuropathy (PDN) were 7,472,695 cases in the seven major markets (7MM) in 2021 and are expected to achieve an AGR of more than 1% during 2021-2031. Diabetic neuropathy refers to a variety of syndromes that differ in clinical course, distribution, and fiber involvement. Symptoms of diabetic neuropathy vary widely from patient to patient, and some patients with diabetic neuropathy have no symptoms. The PDN market research report...
-
Sector Analysis
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Type 2 Diabetes Market Report Overview The T2D market size across the 7MM was valued at $2.43 billion in 2021 and will achieve a CAGR of more than 31% during 2021-2031. The diabetic population is set to grow in line with the increased prevalence of risk factors such as obesity, which will drive market growth during the forecast period. Type 2 Diabetes Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Gain More Information on the Type 2 Diabetes...
-
Product Insights
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Familial Amyloid Neuropathies Pipeline Drugs Market Report Overview Familial amyloid neuropathy is a slowly progressive condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in the body's organs and tissues. Symptoms include numbness, tingling, pins, and needles in the feet and hands, weakness and pain in the arms and legs, loss of sensation, urinary retention, reduced sweating, ankle swelling, fatigue, nausea, weight loss, dizziness, and fainting. The Familial Amyloid Neuropathies pipeline drugs market research report...
-
Product Insights
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hyperglycemia Pipeline Drugs Development Market Report Overview Hyperglycemia is a condition that occurs when blood glucose levels get too high. Several factors can contribute to hyperglycemia, including food and physical activity choices, illness, non-diabetes medications, or not taking enough glucose-lowering medication. Symptoms include frequent urination, blurred vision, fatigue headache, nausea and vomiting, dry mouth, coma and confusion. Treatment includes anti-hyperglycemic therapy and insulin therapy. The Hyperglycemia pipeline drugs market research report provides comprehensive information on the therapeutics under development for...
-
Product Insights
Hyperinsulinemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hyperinsulinemia Drugs Development Market Report Overview Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. Insulin resistance is the primary cause of hyperinsulinemia. Symptoms include weight gain, anxiety, fatigue, and frequent hunger. The Hyperinsulinemia pipeline market research report provides comprehensive information on the therapeutics under development for Hyperinsulinemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pituitary ACTH Hypersecretion Pipeline Drugs Market Report Overview Cushing’s disease is a condition that results from hypersecretion of adrenocorticotropic hormone (ACTH) due to a pituitary gland tumor. Symptoms include acne or skin infections, backache, mental changes (such as depression, anxiety, or changes in behavior), menstrual disorders, and weight gain. Treatment includes radiation, chemotherapy, and the use of certain hormone-inhibiting drugs. The pituitary ACTH hypersecretion pipeline products market research report provides comprehensive information on the therapeutics under development for pituitary ACTH...
-
Sector Analysis
Diabetic Foot Ulcers Treatment Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hospitals and Specialty Clinics, Others) and Segment Forecast, 2022-2027
The diabetic foot ulcers market size was valued at US$ 4.74 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during 2022-2027. The key to the growth has been the rising prevalence of diabetes and resulting increase in incidence of diabetic foot ulcers. Additionally, rise in geriatric population, and increasing adoption of novel biologics and wound care devices for treatment, favoring diabetic foot ulcers market growth.
-
Product Insights
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Diabetic neuropathy is damage to the nerves that allow feeling things such as pain. Symptoms include tingling, numbness, burning, and pain. The Diabetic Neuropathy pipeline drugs market research report provides comprehensive information on the therapeutics under development for Diabetic Neuropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.